bromodeoxyuridine has been researched along with azaserine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Kochhar, DM | 1 |
Baba, M; Iishi, H; Iseki, K; Nakaizumi, A; Tatsuta, M; Uehara, H; Yano, H | 1 |
Ishihara, H; Ishiki, M; Kishida, M; Kobayashi, M; Nakamura, N; Sasaoka, T; Sato, A; Takata, M; Temaru, R; Urakaze, M; Usui, I; Wada, T; Yamazaki, K | 1 |
Bierkamp, C; Clerc, P; Dufresne, M; Fourmy, D; Lulka, H; Mathieu, A; Portolan, G; Pradayrol, L; Seva, C | 1 |
5 other study(ies) available for bromodeoxyuridine and azaserine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
The use of in vitro procedures in teratology.
Topics: Abnormalities, Drug-Induced; Aminopropionitrile; Aminopterin; Animals; Azaserine; Bromodeoxyuridine; Culture Media; Culture Techniques; Diazooxonorleucine; DNA; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryo, Nonmammalian; Embryology; Extremities; Female; Gestational Age; Limb Deformities, Congenital; Niacinamide; Protein Biosynthesis; Teratogens; Thalidomide; Vitamin A; Vitelline Membrane | 1975 |
Inhibition by galanin of experimental carcinogenesis induced by azaserine in rat pancreas.
Topics: Animals; Anticarcinogenic Agents; Azaserine; Body Weight; Bromodeoxyuridine; Carcinogens; Galanin; Male; Norepinephrine; Organ Size; Pancreas; Pancreatic Neoplasms; Rats; Rats, Wistar | 1998 |
Glucosamine enhances platelet-derived growth factor-induced DNA synthesis via phosphatidylinositol 3-kinase pathway in rat aortic smooth muscle cells.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Aorta; Azaserine; Bromodeoxyuridine; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glucosamine; Glucose; GRB2 Adaptor Protein; Isoenzymes; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phospholipase C gamma; Phosphorylation; Platelet-Derived Growth Factor; Proteins; Rats; Receptor, Platelet-Derived Growth Factor beta; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Type C Phospholipases; Tyrosine | 2001 |
Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation.
Topics: Adenoma; Animals; Antimetabolites, Antineoplastic; Azaserine; Bromodeoxyuridine; Carcinogens; Carcinoma, Acinar Cell; Cell Proliferation; Coloring Agents; Homeodomain Proteins; Homozygote; Immunohistochemistry; Inflammation; Lymphocytes; Mice; Mice, Transgenic; Pancreatic Neoplasms; Phenotype; Precancerous Conditions; Receptor, Cholecystokinin B; Receptors, G-Protein-Coupled; Risk; Time Factors; Trans-Activators; Transgenes | 2005 |